TrialBritish journal of cancer2014

EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial.

H Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.